Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis

Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481... Cardiol Ther (2018) 7:89–99 https://doi.org/10.1007/s40119-017-0101-y ORIGINAL RESEARCH Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis . . . . Abdelhakim Allali Erik W. Holy Dmitry S. Sulimov Ralph Toelg Gert Richardt Mohamed Abdel-Wahab Received: August 7, 2017 / Published online: November 21, 2017 The Author(s) 2017. This article is an open access publication p\0.001). The Kaplan–Meier estimated rate of ABSTRACT cardiovascular events at 2 years showed a lower incidence of death (13.5% vs. 8.2%, log-rank Introduction: New-generation drug-eluting p = 0.13; adjusted HR after Cox regression stents (NG-DES) are superior to early generation analysis 0.49; 95% CI 0.26–0.92; p = 0.03) and a DES (EG-DES) in the majority of lesion and lower MACE rate (31.1% vs. 21.1%, log-rank patient subsets, but comparative data in p = 0.04; adjusted HR 0.65; 95% CI 0.42–0.98; patients with severely calcified coronary lesions p = 0.04) in the NG-DES group. are lacking. This study aims to compare clinical Conclusions: Although RA is performed in outcomes of EG-DES and NG-DES in patients more complex patients and lesions in the undergoing rotational atherectomy (RA) in cal- NG-DES era, use of NG-DES is associated with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis

Download PDF
11 pages

Loading next page...
 
/lp/springer-journals/long-term-clinical-outcome-of-early-generation-versus-new-generation-HiGd15eN0U
Publisher
Springer Journals
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-017-0101-y
Publisher site
See Article on Publisher Site

Abstract

Cardiol Ther (2018) 7:89–99 https://doi.org/10.1007/s40119-017-0101-y ORIGINAL RESEARCH Long-Term Clinical Outcome of Early Generation Versus New-Generation Drug-Eluting Stents in 481 Patients Undergoing Rotational Atherectomy: A Retrospective Analysis . . . . Abdelhakim Allali Erik W. Holy Dmitry S. Sulimov Ralph Toelg Gert Richardt Mohamed Abdel-Wahab Received: August 7, 2017 / Published online: November 21, 2017 The Author(s) 2017. This article is an open access publication p\0.001). The Kaplan–Meier estimated rate of ABSTRACT cardiovascular events at 2 years showed a lower incidence of death (13.5% vs. 8.2%, log-rank Introduction: New-generation drug-eluting p = 0.13; adjusted HR after Cox regression stents (NG-DES) are superior to early generation analysis 0.49; 95% CI 0.26–0.92; p = 0.03) and a DES (EG-DES) in the majority of lesion and lower MACE rate (31.1% vs. 21.1%, log-rank patient subsets, but comparative data in p = 0.04; adjusted HR 0.65; 95% CI 0.42–0.98; patients with severely calcified coronary lesions p = 0.04) in the NG-DES group. are lacking. This study aims to compare clinical Conclusions: Although RA is performed in outcomes of EG-DES and NG-DES in patients more complex patients and lesions in the undergoing rotational atherectomy (RA) in cal- NG-DES era, use of NG-DES is associated with

Journal

Cardiology and Therapy – Springer Journals

Published: Nov 21, 2017

References

  • European expert consensus on rotational atherectomy
    Barbato, E; Carrié, D; Dardas, P; Fajadet, J; Gaul, G; Haude, M; Khashaba, A; Koch, K; Meyer-Gessner, M; Palazuelos, J; Reczuch, K; Ribichini, FL; Sharma, S; Sipötz, J; Sjögren, I; Suetsch, G; Szabó, G; Valdés-Chávarri, M; Vaquerizo, B; Wijns, W; Windecker, S; Belder, A; Valgimigli, M; Byrne, RA; Colombo, A; Mario, C; Latib, A; Hamm, C
  • Current status of rotational atherectomy
    Tomey, MI; Kini, AS; Sharma, SK
  • Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study
    Reifart, N; Vandormael, M; Krajcar, M; Göhring, S; Preusler, W; Schwarz, F; Störger, H; Hofmann, M; Klöpper, J; Müller, S; Haase, J
  • Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART)
    Mauri, L; Reisman, M; Buchbinder, M; Popma, JJ; Sharma, SK; Cutlip, DE; Ho, KK; Prpic, R; Zimetbaum, PJ; Kuntz, RE
  • Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results
    Moussa, I; Mario, C; Moses, J; Reimers, B; Francesco, L; Martini, G; Tobis, J; Colombo, A
  • Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results
    Khattab, AA; Otto, A; Hochadel, M; Toelg, R; Geist, V; Richardt, G
  • Percutaneous coronary intervention in heavily calcified lesions using rotational atherectomy and paclitaxel-eluting stents: outcomes at one year
    de Lara Lara, J; Pinar, E; Ramón Gimeno, J; Hurtado, JAA; Lacunza, J; Valdesuso, R; Valdés, Chávarri M
  • Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions
    Abdel-Wahab, M; Baev, R; Dieker, P; Kassner, G; Khattab, AA; Toelg, R; Sulimov, D; Geist, V; Richardt, G
  • Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions
    Furuichi, S; Sangiorgi, GM; Godino, C; Airoldi, F; Montorfano, M; Chieffo, A; Michev, I; Carlino, M; Colombo, A
  • High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial
    Abdel-Wahab, M; Richardt, G; Joachim Büttner, H; Toelg, R; Geist, V; Meinertz, T; Schofer, J; King, L; Neumann, F-JJ; Khattab, AA
  • Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial
    Waha, S; Allali, A; Büttner, H-JJ; Toelg, R; Geist, V; Neumann, F-JJ; Khattab, AA; Richardt, G; Abdel-Wahab, M
  • Drug-eluting coronary-artery stents
    Stefanini, GG; Holmes, DR
  • Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials
    Planer, D; Smits, PC; Kereiakes, DJ; Kedhi, E; Fahy, M; Xu, K; Serruys, PW; Stone, GW
  • Clinical outcomes of first- and second-generation drug-eluting stents in patients undergoing rotational atherectomy for heavily calcified coronary lesions
    Tian, W; Mahmoudi, M; Lhermusier, T; Pendyala, LK; Kiramijyan, S; Saar, M; Ota, H; Chen, F; Torguson, R; Suddath, WO; Satler, LF; Pichard, AD; Waksman, R
  • Clinical end points in coronary stent trials: a case for standardized definitions
    Cutlip, DE; Windecker, S; Mehran, R; Boam, A; Cohen, DJ; Es, G-AA; Steg, PG; Morel, MA; Mauri, L; Vranckx, P; McFadden, E; Lansky, A; Hamon, M; Krucoff, MW; Serruys, PW
  • Coronary calcification improves cardiovascular risk prediction in the elderly
    Vliegenthart, R; Oudkerk, M; Hofman, A; Oei, H-HSH; Dijck, W; Rooij, FJ; Witteman, JC
  • Stent deployment in calcified lesions: can we overcome calcific restraint with high-pressure balloon inflations?
    Vavuranakis, M; Toutouzas, K; Stefanadis, C; Chrisohou, C; Markou, D; Toutouzas, P
  • Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience
    Tan, K; Sulke, N; Taub, N; Sowton, E
  • Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon
    Ribamar, Costa J; Mintz, GS; Carlier, SGG; Mehran, R; Teirstein, P; Sano, K; Liu, X; Lui, J; Na, Y; Castellanos, C; Biro, S; Dani, L; Rinker, J; Moussa, I; Dangas, G; Lansky, AJ; Kreps, EM; Collins, M; Stone, GW; Moses, JW; Leon, MB
  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Windecker, S; Kolh, P; Alfonso, F; Collet, J-PP; Cremer, J; Falk, V; Filippatos, G; Hamm, C; Head, SJ; Jüni, P; Kappetein, AP; Kastrati, A; Knuuti, J; Landmesser, U; Laufer, G; Neumann, F-JJ; Richter, DJ; Schauerte, P; Sousa Uva, M; Stefanini, GG; Taggart, DP; Torracca, L; Valgimigli, M; Wijns, W; Witkowski, A
  • Coronary artery calcification: pathogenesis and prognostic implications
    Madhavan, MV; Tarigopula, M; Mintz, GS; Maehara, A; Stone, GW; Généreux, P
  • Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS
    Généreux, P; Madhavan, MV; Mintz, GS; Maehara, A; Palmerini, T; Lasalle, L; Xu, K; McAndrew, T; Kirtane, A; Lansky, AJ; Brener, SJ; Mehran, R; Stone, GW
  • Lower risk of stent thrombosis and restenosis with unrestricted use of “new-generation” drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
    Sarno, G; Lagerqvist, B; Fröbert, O; Nilsson, J; Olivecrona, G; Omerovic, E; Saleh, N; Venetzanos, D; James, S
  • Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans
    Otsuka, F; Vorpahl, M; Nakano, M; Foerst, J; Newell, JB; Sakakura, K; Kutys, R; Ladich, E; Finn, AV; Kolodgie, FD; Virmani, R
  • Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
    Dangas, GD; Serruys, PW; Kereiakes, DJ; Hermiller, J; Rizvi, A; Newman, W; Sudhir, K; Smith, RS; Cao, S; Theodoropoulos, K; Cutlip, DE; Lansky, AJ; Stone, GW
  • Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus
    Stone, GW; Kedhi, E; Kereiakes, DJ; Parise, H; Fahy, M; Serruys, PW; Smits, PC
  • Rotational atherectomy in very long lesions: Results for the ROTATE registry
    Iannaccone, M; Barbero, U; D’ascenzo, F; Latib, A; Pennacchi, M; Rossi, ML; Ugo, F; Meliga, E; Kawamoto, H; Moretti, C; Ielasi, A; Garbo, R; Colombo, A; Sardella, G; Boccuzzi, GG